VO Shapovalova1, SI Zbrozhek1, EV Suprun1, VV Shapovalov1-4* and VV Shapovalov5
1Kharkiv Medical Academy of Postgraduate Education, Kharkiv, Ukraine
2Ukrainian National Bar Association, Kyiv, Ukraine
3Advocates Company “Apotheosis”, Kharkiv, Ukraine
4Public Organization “Association of Medical and Pharmaceutical Law”, Kharkiv, Ukraine
5Healthcare Department of Kharkiv Regional State Administration, Kharkiv, Ukraine
*Corresponding Author: VV Shapovalov, Kharkiv Medical Academy of Postgraduate Education, Kharkiv, Ukraine.
Received: June 02, 2020; Published: July 01, 2020
The article is devoted to the problem of the emergence in 2019 of diseases caused by the new coronavirus (“coronavirus disease 2019”), which have already gone down in history as an emergency of international importance. The most common clinical manifestation of a new infection is pneumonia, and in a significant proportion of patients - respiratory distress syndrome. A virological, epidemiological and clinical study of severe acute respiratory syndrome, Middle East respiratory syndrome and the outbreak of acute respiratory diseasein 2019-2020 was compared in Wuhan (Hubei, People's Republic of China, China). Analysis of the scientific literature data on the coronavirus disease pandemic 2019 based on the systematization, synthesis and comparison of documentary data regarding: historical aspects of the study of coronaviruses; severe acute respiratory syndrome; Middle Eastern Respiratory Syndrome; SARS-CoV-2 virus disease COVID-19; comparative characteristics of SARS/MERS/COVID-19. When conducting the study, we used the current legislative, regulatory and instructive documents, Internet resources. They used regulatory, documentary, bibliographic, comparative and graphical methods of analysis. The article presents the results of a comparison of the virological, epidemiological and clinical studies of severe acute respiratory syndrome, Middle East respiratory syndrome and the outbreak of acute respiratory disease in 2019-2020 years in Wuhan (Hubei, People's Republic of China, China). Established that the etiological agent of COVID-19 is coronavirus, phylogenetically close to the causative agent of SARS (SARS-related human CoV virus) and related coronaviruses isolated from bats (SARS-related bat CoV viruses). The data obtained are the basis for the need to continue further research and reviews of the coronavirus pandemic in the direction of finding methods for effective treatment of patients with this pathology.
Keywords: Coronavirus; Epidemic Hazard; Pandemic; Severe Acute Respiratory Syndrome (SARS); Middle East Respiratory Syndrome (MERS); COVID-19 Diseases Caused by the SARS-CoV-2 Virus
Citation: VV hapovalov., et al. “Coronavirus Disease Pandemia 2019: Growth of Epidemic Dangers". Acta Scientific Pharmaceutical Sciences 4.7 (2020): 61-68.
Copyright: © 2020 VV hapovalov., et al. This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.